OSUR
ORASURE TECHNOLOGIES INCCompany Information
- Company Name
- ORASURE TECHNOLOGIES INC
- CIK
- CIK0001116463
- Category
- Accelerated filer
- Ticker: Exchange
- OSUR: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- OSUR
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-05-14
- Last sale
- 2023-12-19
- Shares purchased (TTM)
- 135,743
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 48,997,225
- Shares outstanding
- 69,003,000
- Ownership
- 71.01%
Earnings Market Reaction
- Filing date
- 2026-08-07
- Price on filing date
- —
- 1-month reaction
- -11.11%
- 3-month reaction
- Pending
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 161 | 177 | 199 | 216 | 235 | 248 | 268 | 279 | 258 | 247 | 290 | 218 | ||||||
| Short Term Investments | - | - | - | - | - | - | - | - | 9 | 17 | 0 | 7 | ||||||
| Accounts Receivable Net Current | 26 | 25 | 22 | 24 | 26 | 22 | 24 | 27 | 38 | 34 | 40 | 53 | ||||||
| Inventory Net | 30 | 30 | 31 | 33 | 33 | 36 | 34 | 39 | 38 | 43 | 48 | 59 | ||||||
| Prepaid Expense Current | 3 | 5 | 5 | 5 | 3 | 6 | 4 | 3 | 4 | 5 | 6 | 6 | ||||||
| Income Tax Receivable | 2 | 2 | - | - | - | - | - | - | - | - | - | - | ||||||
| Other Assets Current | 2 | 2 | 4 | 4 | 4 | 3 | 3 | 3 | 4 | 3 | 2 | 12 | ||||||
| Assets Current | 223 | 241 | 262 | 283 | 301 | 314 | 333 | 350 | 351 | 349 | 386 | 356 | ||||||
Assets Noncurrent | ||||||||||||||||||
| Property Plant And Equipment Net | 39 | 38 | 39 | 41 | 42 | 43 | 45 | 38 | 40 | 43 | 45 | 48 | ||||||
| Operating Lease Right Of Use Asset | 11 | 12 | 12 | 12 | 13 | 13 | 13 | 10 | 10 | 11 | 12 | 13 | ||||||
| Finance Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | ||||||
| Intangible Assets Net Excluding Goodwill | 19 | 19 | 19 | 17 | 17 | 17 | 17 | 1 | 1 | 1 | 1 | 4 | ||||||
| Goodwill | 43 | 43 | 43 | 41 | 42 | 40 | 40 | 35 | 35 | 35 | 36 | 35 | ||||||
| Equity Securities F V N I Noncurrent | 24 | 25 | 26 | 27 | 27 | 28 | 28 | 29 | 28 | 28 | 0 | - | ||||||
| Deferred Income Tax Assets Net | 0 | 1 | 0 | 0 | 0 | 1 | 0 | - | - | - | 0 | 0 | ||||||
| Other Assets Noncurrent | 1 | 1 | 1 | 2 | 3 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | ||||||
| Assets Noncurrent | 138 | 138 | 141 | 140 | 144 | 144 | 146 | 114 | 115 | 119 | 96 | 102 | ||||||
| Assets | 361 | 379 | 403 | 423 | 445 | 458 | 480 | 464 | 466 | 468 | 483 | 458 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 8 | 11 | 7 | 6 | 6 | 8 | 8 | 10 | 9 | 13 | 13 | 15 | ||||||
| Contract With Customer Liability | - | - | - | - | - | - | 3 | - | - | - | 2 | - | ||||||
| Contract With Customer Liability Current | 1 | 1 | 2 | 2 | 2 | 3 | 3 | 2 | 1 | 2 | - | 2 | ||||||
| Finance Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | ||||||
| Operating Lease Liability Current | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Business Combination Contingent Consideration Liability Current | 0 | 19 | 18 | 17 | 17 | - | 0 | - | - | - | 0 | 0 | ||||||
| Liabilities Current | 25 | 44 | 40 | 40 | 42 | 25 | 33 | 28 | 29 | 29 | 40 | 41 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Finance Lease Liability Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Liability Noncurrent | 10 | 10 | 11 | 11 | 12 | 12 | 12 | 9 | 10 | 11 | 11 | 12 | ||||||
| Business Combination Contingent Consideration Liability Noncurrent | 5 | 9 | 9 | 7 | 7 | 23 | 23 | - | - | - | 0 | 0 | ||||||
| Other Liabilities Noncurrent | 2 | 2 | 2 | 2 | 3 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | ||||||
| Deferred Income Tax Liabilities Net | - | - | - | - | - | - | 0 | 1 | 1 | 1 | 1 | 0 | ||||||
| Liabilities Noncurrent | 18 | 22 | 23 | 21 | 22 | 36 | 36 | 11 | 12 | 12 | 13 | 13 | ||||||
| Liabilities | 43 | 66 | 62 | 61 | 64 | 61 | 69 | 39 | 41 | 41 | 52 | 54 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 528 | 528 | 531 | 535 | 537 | 540 | 538 | 535 | 533 | 531 | 530 | 526 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -22 | -20 | -18 | -20 | -17 | -24 | -24 | -17 | -19 | -17 | -15 | -17 | ||||||
| Retained Earnings Accumulated Deficit | -188 | -195 | -172 | -153 | -139 | -119 | -103 | -93 | -88 | -88 | -84 | -104 | ||||||
| Stockholders Equity | 318 | 313 | 341 | 362 | 381 | 396 | 410 | 426 | 426 | 426 | 431 | 405 | ||||||
| Liabilities And Stockholders Equity | 361 | 379 | 403 | 423 | 445 | 458 | 480 | 464 | 466 | 468 | 483 | 458 | ||||||
| Accumulated Depreciation Depletion And Amortization Property Plant And Equipment | - | 65 | - | 73 | 71 | 68 | - | 80 | 89 | 86 | - | 84 | ||||||
| Allowance For Doubtful Accounts Receivable Current | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 2 | ||||||
| Finite Lived Intangible Assets Accumulated Amortization | 27 | 27 | - | 27 | 27 | 26 | - | 34 | 33 | 33 | - | 27 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 120 | 120 | 120 | 120 | 120 | 120 | 120 | 120 | 120 | 120 | 120 | 120 | ||||||
| Common Stock Shares Issued | 69 | 69 | 70 | 72 | 74 | 75 | 75 | 75 | 75 | 74 | 74 | 73 | ||||||
| Shares Outstanding | 69 | 69 | 70 | 72 | 74 | 75 | 75 | 75 | 75 | 74 | 74 | 73 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialORASURE TECHNOLOGIES INC (OSUR) — SEC Financial Statements & Analysis
ORASURE TECHNOLOGIES INC (OSUR) is a surgical & medical instruments & apparatus company, incorporated in DE. ORASURE TECHNOLOGIES INC trades on Nasdaq as: OSUR. ORASURE TECHNOLOGIES INC (OSUR)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-07. Based on that filing, ORASURE TECHNOLOGIES INC carries a market cap of $307.75M, a P/E ratio of -6.26x, a P/B ratio of 0.97x, a P/S ratio of 2.74x, an enterprise value of $147.38M, and an EV/EBITDA multiple of -3.32x. On profitability, it posts a gross margin of 42.58%, an operating margin of -48.06%, a net margin of -43.70%, a Return on Equity (ROE) of -14.07%, a Return on Assets (ROA) of -12.20%, and a Return on Invested Capital (ROIC) of -34.90%. Per share, it reports EPS of $-0.71, diluted EPS of $-0.70, free cash flow per share of $-0.70, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -18.86% year-over-year, net income growth of -3.74% year-over-year, and EPS growth of 3.99% year-over-year. On the balance sheet, it maintains a current ratio of 8.88x, a quick ratio of 7.54x, working capital of $197.82M, a debt-to-equity ratio of 0.13x, a debt ratio of 0.12, free cash flow of $-48.06M (TTM), and net debt of $-160.38M. Figures sourced from SEC EDGAR.
- Market Cap
- $307.75M
- P/E TTM
- -6.26x
- EPS TTM
- $-0.71
- P/B TTM
- 0.97x
- ROE TTM
- -14.07%
- ROA TTM
- -12.20%
- Debt To Equity
- 0.13x
- Free Cash Flow TTM
- $-48.06M
- Net Revenue TTM Growth 1Y
- -18.86%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is ORASURE TECHNOLOGIES INC in?
ORASURE TECHNOLOGIES INC (OSUR) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does OSUR trade on?
ORASURE TECHNOLOGIES INC (OSUR) trades on the Nasdaq.
Where is ORASURE TECHNOLOGIES INC incorporated?
ORASURE TECHNOLOGIES INC is incorporated in DE.
When was ORASURE TECHNOLOGIES INC (OSUR)'s most recent SEC filing?
ORASURE TECHNOLOGIES INC (OSUR)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-07.
What is OSUR's market cap?
ORASURE TECHNOLOGIES INC (OSUR) has a market capitalization of $307.75M as of 2026-06-30.
What is OSUR's EPS (earnings per share)?
ORASURE TECHNOLOGIES INC (OSUR)'s trailing twelve month EPS is $-0.71 as of 2026-06-30.
What is OSUR's ROE (return on equity)?
ORASURE TECHNOLOGIES INC (OSUR)'s trailing twelve month Return on Equity (ROE) is -14.07% as of 2026-06-30.
What is OSUR's ROA (return on assets)?
ORASURE TECHNOLOGIES INC (OSUR)'s trailing twelve month Return on Assets (ROA) is -12.20% as of 2026-06-30.
What is OSUR's ROIC (return on invested capital)?
ORASURE TECHNOLOGIES INC (OSUR)'s trailing twelve month Return on Invested Capital (ROIC) is -34.90% as of 2026-06-30.
What is OSUR's EV/EBITDA?
ORASURE TECHNOLOGIES INC (OSUR)'s trailing twelve month EV/EBITDA is -3.32x as of 2026-06-30.